Algert Global’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.68M | Buy |
180,965
+47,368
| +35% | +$964K | 0.08% | 432 |
|
|
2025
Q1 | $2.43M | Buy |
133,597
+29,260
| +28% | +$531K | 0.06% | 541 |
|
|
2024
Q4 | $2.64M | Buy |
104,337
+49,354
| +90% | +$1.25M | 0.06% | 513 |
|
|
2024
Q3 | $1.87M | Sell |
54,983
-20,631
| -27% | -$701K | 0.05% | 569 |
|
|
2024
Q2 | $2.8M | Buy |
75,614
+32,564
| +76% | +$1.2M | 0.09% | 356 |
|
|
2024
Q1 | $1.81M | Buy |
43,050
+33,140
| +334% | +$1.39M | 0.07% | 442 |
|
|
2023
Q4 | $393K | Sell |
9,910
-18,920
| -66% | -$750K | 0.02% | 883 |
|
|
2023
Q3 | $793K | Sell |
28,830
-10,650
| -27% | -$293K | 0.04% | 616 |
|
|
2023
Q2 | $1.34M | Buy |
39,480
+15,844
| +67% | +$538K | 0.06% | 551 |
|
|
2023
Q1 | $850K | Buy |
23,636
+15,343
| +185% | +$552K | 0.04% | 694 |
|
|
2022
Q4 | $370K | Sell |
8,293
-14,740
| -64% | -$658K | 0.02% | 887 |
|
|
2022
Q3 | $647K | Buy |
23,033
+4,188
| +22% | +$118K | 0.04% | 722 |
|
|
2022
Q2 | $508K | Buy |
18,845
+4,860
| +35% | +$131K | 0.04% | 754 |
|
|
2022
Q1 | $476K | Buy |
13,985
+6,800
| +95% | +$231K | 0.03% | 830 |
|
|
2021
Q4 | $278K | Sell |
7,185
-970
| -12% | -$37.5K | 0.03% | 761 |
|
|
2021
Q3 | $440K | Buy |
+8,155
| New | +$440K | 0.06% | 588 |
|
|
2021
Q1 | – | Sell |
-10,980
| Closed | -$192K | – | 453 |
|
|
2020
Q4 | $192K | Sell |
10,980
-34,090
| -76% | -$596K | 0.05% | 348 |
|
|
2020
Q3 | $668K | Buy |
+45,070
| New | +$668K | 0.21% | 159 |
|